205 related articles for article (PubMed ID: 36930265)
1. [Cancer of unknown primary-The new ESMO guidelines].
Bochtler T; Pouyiourou M; Krämer A
Radiologie (Heidelb); 2023 May; 63(5):329-335. PubMed ID: 36930265
[TBL] [Abstract][Full Text] [Related]
2. [Cancer of unknown primary (CUP)-single-site, oligometastatic, and in the head and neck region].
Pouyiourou M; Regnery S; Bochtler T; Herfarth K; Krämer A
Radiologie (Heidelb); 2023 May; 63(5):358-365. PubMed ID: 36944857
[TBL] [Abstract][Full Text] [Related]
3. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
Greco FA; Hainsworth JD
Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
[TBL] [Abstract][Full Text] [Related]
4. A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
Pauli C; Bochtler T; Mileshkin L; Baciarello G; Losa F; Ross JS; Pentheroudakis G; Zarkavelis G; Yalcin S; Özgüroğlu M; Beringer A; Scarato J; Mueller-Ohldach M; Thomas M; Moch H; Krämer A
Oncologist; 2021 May; 26(5):e769-e779. PubMed ID: 33687747
[TBL] [Abstract][Full Text] [Related]
5. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma.
Kanesvaran R; Porta C; Wong A; Powles T; Ng QS; Schmidinger M; Ye D; Malhotra H; Miura Y; Lee JL; Chong FLT; Pu YS; Yen CC; Saad M; Lee HJ; Kitamura H; Bhattacharyya GS; Curigliano G; Poon E; Choo SP; Peters S; Lim E; Yoshino T; Pentheroudakis G
ESMO Open; 2021 Dec; 6(6):100304. PubMed ID: 34864348
[TBL] [Abstract][Full Text] [Related]
6. [CUP syndrome-diagnostics from the perspective of pathology].
Pauli C
Radiologie (Heidelb); 2023 May; 63(5):336-345. PubMed ID: 37079060
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia.
Boys EL; Gao B; Grimison P; Sutherland S; MacKenzie KL; Reddel RR; Liu J
Cancer Med; 2024 Mar; 13(6):e7052. PubMed ID: 38523552
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
9. Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary.
Pouyiourou M; Wohlfromm T; Kraft B; Hielscher T; Stichel D; von Deimling A; Delorme S; Endris V; Neumann O; Stenzinger A; Krämer A; Bochtler T
Eur J Cancer; 2021 Nov; 157():179-189. PubMed ID: 34521064
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
[TBL] [Abstract][Full Text] [Related]
11. CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.
Zaun G; Schuler M; Herrmann K; Tannapfel A
Dtsch Arztebl Int; 2018 Mar; 115(10):157-162. PubMed ID: 29587959
[TBL] [Abstract][Full Text] [Related]
12. The current management of renal cell carcinoma.
Kuusk T; Grivas N; de Bruijn R; Bex A
Minerva Med; 2017 Aug; 108(4):357-369. PubMed ID: 28176516
[TBL] [Abstract][Full Text] [Related]
13. [The initial CUP situation and CUP syndrome: pathological diagnostics].
Moll R
Pathologe; 2009 Dec; 30 Suppl 2():161-7. PubMed ID: 19816686
[TBL] [Abstract][Full Text] [Related]
14. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
Briasoulis E; Tolis C; Bergh J; Pavlidis N;
Ann Oncol; 2005; 16 Suppl 1():i75-6. PubMed ID: 15888766
[No Abstract] [Full Text] [Related]
15. Papillary renal cell carcinoma: current and controversial issues.
Angori S; Lobo J; Moch H
Curr Opin Urol; 2022 Jul; 32(4):344-351. PubMed ID: 35674688
[TBL] [Abstract][Full Text] [Related]
16. Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective.
Weiss L; Heinrich K; Zhang D; Dorman K; Rühlmann K; Hasselmann K; Klauschen F; Kumbrink J; Jung A; Rudelius M; Mock A; Ormanns S; Kunz WG; Roessler D; Beyer G; Corradini S; Heinzerling L; Haas M; von Bergwelt-Baildon M; Boeck S; Heinemann V; Westphalen CB
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8225-8234. PubMed ID: 37062035
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.
Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1208-1215. PubMed ID: 27812692
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Escudier B; Kataja V;
Ann Oncol; 2009 May; 20 Suppl 4():81-2. PubMed ID: 19454473
[No Abstract] [Full Text] [Related]
19. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
Oien KA; Dennis JL
Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Escudier B; Porta C; Schmidinger M; Algaba F; Patard JJ; Khoo V; Eisen T; Horwich A;
Ann Oncol; 2014 Sep; 25 Suppl 3():iii49-56. PubMed ID: 25210086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
